Health Care Valuations Hit 20-Year High

Investors with heavy health care exposure may want to review how their sector mix compares with technology holdings.

Updated on Nov. 7, 2026 in Stock Picks

Bold vector editorial illustration of two unequal stacks of teal and oxblood blocks linked by a balance beam on a cream background.
Raymond James Chief Investment Officer Larry Adam urged investors to shift holdings from health care toward technology, citing health care valuations at a 20-year high. AI Illustration. Upload story photo >

Live Poll

Would you change your own investments based on advice to shift from health care to tech?

Raymond James Chief Investment Officer Larry Adam favors shifting investment from health care toward technology, citing health care valuations at their highest level in 20 years. The view was reported for U.S. investors weighing sector allocation in their portfolios.

Why it matters

Adam's argument centers on valuation: when a sector trades at elevated prices, expected returns from that sector may be lower going forward, which is why he points investors toward technology. For households with retirement accounts or brokerage holdings, sector tilts like this can shift how much of a portfolio is exposed to a single area of the market.

Health care valuations are at their highest level in 20 years, measured against the prior two decades of sector pricing. Adam's recommendation rests on that comparison, but the extraction does not provide specific multiples or a numeric return forecast for either sector.

The players

Raymond James

A U.S. brokerage and wealth management firm whose investment research and advisory recommendations reach individual investors and retirement account holders.

Larry Adam

Chief Investment Officer at Raymond James, whose sector views guide the firm's market commentary for investors deciding how to allocate their portfolios.

The details

Valuation measures how much investors pay for each dollar of a company's earnings, and when that price rises well above a sector's historical norm, future gains can be harder to achieve. Adam's view is that investment favor is directed toward mega-cap technology companies, semiconductor infrastructure, cybersecurity stocks, and hyperscalers. He notes that companies higher in the capitalization structure are favored for financing advantages and lower sensitivity to interest rates. Some AI and semiconductor stocks are valued at a discount, and earnings projections for some technology companies have been revised upward.

Timeline

  1. Views were reported as of November 7, 2026.

Money Landscape

Adam's call reflects a broader debate among strategists about whether elevated sector valuations warrant rebalancing, since high starting prices can compress future returns. The view is one input among many that investors weigh when deciding how concentrated a portfolio should be in any single industry.

If your retirement or brokerage account holds a large share of health care stocks, Adam's view suggests reviewing how much of your portfolio sits in that sector relative to technology. Changes to sector weightings are worth discussing with a qualified financial professional before acting, since the right balance depends on your own goals and time horizon.

The takeaway

Valuation is a useful lens for checking whether a sector's price already reflects its prospects, and it can help you see how concentrated your holdings have become. Consider reviewing your sector mix with a qualified financial professional so that any shift matches your own risk tolerance.

Further reading

For more on how analysts weigh sector picks against valuations, explore Stock Picks in our personal finance coverage.

Source note: This article includes information reported by TokenPost.

Live Poll

Would you change your own investments based on advice to shift from health care to tech?